Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.

Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.

Journal of medicinal chemistry (2008-08-09)

Arumugam Kodimuthali, S Sugin Lal Jabaris, Manojit Pal

MATERIALS

Product Number

Brand

Product Description

Sigma-Aldrich

(±)-Thalidomide, ≥98%, powder